At a glance
ClinicalIndex Comparison RecordN/ACompleted· 196 enrolled
Drug / intervention
AquaComfort Plus +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Late Night Study 2: End-of-Day Assessment of Asymptomatic and Symptomatic Soft Lens Wearers
In Brief
A clinical study evaluating AquaComfort Plus and Acuvue Oasys 1-Day for Visual Acuity. Completed, enrolled 196 participants across 1 site.
Detailed Summary
This is a 2-Part, 8-Visit, single-center, open-label, bilateral and dispensing clinical study. In Part 1 (Visits 1-4) all subjects will be Test Lens 1, in Part 2 (Visits 1-4) eligible subjects will be dispensed Test Lens 2 based on their responses to the CLDEQ-8 questionnaire. Subjects scoring between 11 and 19 on the CLDEQ will not continue into Part 2
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedMar 2019
Enrollment StartApr 2019
Primary CompletionFeb 2022
TodayJul 2026
First PostedMar 12, 2019
Enrollment StartApr 1, 2019
Primary CompletionFeb 3, 2022
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 7.3 years ago
Interventions
AquaComfort Plusdevice
Test Lens 1
Acuvue Oasys 1-Daydevice
Test Lens 2